Last updated on February 2018

The Mechanism of Modified Utral-long Protocol in Improving Endometrial Receptivity in Patients With PCOS and IR

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Polycystic Ovary Syndrome
  • Age: Between 20 - 35 Years
  • Gender: Female

Inclusion Criteria:

  • age36years,
  • PCOS,
  • Insulin resistance (HOMA-IR = fasting insulin (FINS) fasting blood glucose (FPG) / 22.5, HOMA-IR 2.69 ;

Exclusion Criteria:

  • uterine abnormalities (double uterus, bicornuate uterus, unicornuate uterus and uterine mediastinum),
  • intrauterine adhesions,
  • endometriosis, adenomyosis,
  • Hydrosalpinx,
  • uterine fibroids (submucosal fibroids, non-mucosal fibroids > 4 cm and / or endometrial pressure),
  • Hyroid dysfunction and hyperprolactinemia.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.